Interindividual variability in the human metabolism of ellagic acid: Contribution of Gordonibacter to urolithin production

Journal of Functional Foods

Volumn 17, Issue , 2015, Pages 785-791

  Romo Vaquero, María ^a   García Villalba, Rocío ^a   González Sarrías, Antonio ^a   Beltrán, David ^a   Tomás Barberán, Francisco A ^a   Espín, Juan C ^a   Selma, María V ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Ellagitannin; Gut microbiota; Polyphenols; Pomegranate; Quantitative qPCR; Walnut

Indexed keywords

JUGLANS; LYTHRACEAE;

EID: 84938848667     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.06.040     Document Type: Article

References (27)

1. Baranyi J., Roberts T.A., McClure P. A non-autonomous different equation to model bacterial growth. Food Microbiology 1993, 10:43-59.
2. Bode L.M., Bunzel D., Huch M., Cho G.S., Ruhland D., Bunzel M., Bub A., Franz C.M., Kulling S.E. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. The American Journal of Clinical Nutrition 2013, 97:295-309.
3. Bolca S., Van de Wiele T., Possemiers S. Gut metabotypes govern health effects of dietary polyphenols. Current Opinion in Biotechnology 2013, 24:220-225.
4. Cerdá B., Espín J.C., Parra S., Martínez P., Tomás-Barberán F.A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. European Journal of Nutrition 2004, 44:205-220.
5. Chen H., Sang S. Biotransformation of tea polyphenols by gut microbiota. Journal of Functional Foods 2014, 7:26-42.
6. Chiou Y.-S., Wu J.C., Huang O., Shahidi F., Wang Y.-J., Ho C.-T., Pan M.-H. Metabolic and colonic microbiota transformation may enhance the bioactivities of dietary polyphenols. Journal of Functional Foods 2014, 7:3-25.
7. Clavel T., Henderson G., Alpert C.A., Philippe C., Rigottier-Gois L., Doré J., Blaut M. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Applied and Environmental Microbiology 2005, 71:6077-6085.
8. Espín J.C., Larrosa M., García-Conesa M.T., Tomás-Barberán F.A. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: The evidence so far. Evidence-based Complementary and Alternative Medicine 2013, 2013:1-15. 10.1155/2013/270418.
9. Furet J.P., Firmesse O., Gourmelon M., Bridonneau C., Tap J., Mondot S., Doré J., Corthier G. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiology Ecology 2009, 68:451-462.
10. García-Villalba R., Beltrán D., Espín J.C., Selma M.V., Tomás-Barberán F.A. Time course production of urolithins from ellagic acid by human gut microbiota. Journal of Agricultural and Food Chemistry 2013, 61:8797-8806.
11. Guo X., Xia X., Tang R., Zhou J., Zhao H., Wang K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters in Applied Microbiology 2008, 47:467-474.
12. Kim M., Kim S., Han J., Wang X., Song D., Kim S. Stereospecific biotransformation of dihydrodaidzein into (3s)-equol by the human intestinal bacterium Eggerthella strain Julong 732. Applied and Environmental Microbiology 2009, 75:3062-3068.
13. Madrigal-Carballo S., Rodriguez G., Krueger C.G., Dreher M., Reed J.D. Pomegranate (Punica granatum) supplements: Authenticity, antioxidant and polyphenol composition. Journal of Functional Foods 2009, 1:324-329.
14. Maidak B.L., Cole J.R., Lilburn T.G., Parker C.T., Saxman P.R., Farris R.J., Garrity G.M., Olsen G.J., Schmidt T.M., Tiedje J.M. The RDP-II (Ribosomal Database Project). Nucleic Acids Research 2001, 1:174.
15. Maruo T., Sakamoto M., Ito C., Toda T., Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. International Journal of Systematic and Evolutionary Microbiology 2008, 58:1221-1227.
16. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., Oyaizu H., Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human faeces. Applied and Environmental Microbiology 2002, 68:5445-5451.
17. Matthies A., Blaut M., Braune A. Isolation of a human intestinal bacteria capable of daidzein and genistein conversion. Applied and Environmental Microbiology 2009, 75:1740-1744.
18. Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. Journal of Agricultural and Food Chemistry 2006, 54:8956-8961.
19. Nuñez-Sánchez M.A., García-Villalba R., Monedero-Saiz T., García-Talavera N.V., Gómez-Sánchez M.B., Sánchez-Alvarez C., García-Albert A.M., Rodríguez-Gil F.J., Ruiz-Marín M., Pastor-Quirante F.A., Martínez-Díaz F., Yáñez-Gascón M.J., Gonzáñez-Sarrías A., Tomás-Barberán F.A., Espín J.C. Targeted metabolomics profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Molecular Nutrition and Food Research 2014, 58:1199-1211.
20. Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., De Keukeleire D., Sylvie Rabot S., Verstraete W., Van de Wiele T. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. Journal of Nutrition 2006, 146:1862-1867.
21. Seeram N.P., Henning S.M., Zhang Y., Suchard M., Li Z., Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. Journal of Nutrition 2006, 146:2481-2485.
22. Selma M.V., Beltrán D., García-Villalba R., Espín J.C., Tomás-Barberán F.A. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food and Function 2014, 5:1779-1784.
23. Selma M.V., Espín J.C., Tomás-Barberán F.A. Interaction between phenolics and gut microbiota: Role in human health. Journal of Agricultural and Food Chemistry 2009, 57:6485-6501.
24. Selma M.V., Tomás-Barberán F., Beltrán D., García-Villalba R., Espín J.C. Gordonibacter urolithinfaciens sp. nov., an urolithin-producing bacterium isolated from human gut. International Journal of Systematic and Evolutionary Microbiology 2014, 64:2446-2452.
25. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTALW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 1994, 22:4674-4680.
26. Tomás-Barberán F.A., García-Villalba R., González-Sarrías A., Selma M.V., Espín J.C. Ellagic acid metabolism by human gut microbiota: Consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. Journal of Agricultural and Food Chemistry 2014, 62:6545-6548.
27. Wang X., Hur H., Lee J.H., Kim K.T., Kim S. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Applied and Environmental Microbiology 2005, 71:214-219.